Corneal light scattering after CXL gives distinctive spatial and temporal profiles

Article

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients.

The spatial distribution and temporal profiles of corneal light scattering after corneal collagen crosslinking (CXL) are distinctive in keratoconus patients, states a study published by the Journal of Cataract and Refractive Surgery.

A team led by Dr Anders Behndig, Department of Clinical Sciences and Ophthalmology, Umeå University, Sweden, included 11 eyes in a case series of 11 keratoconus patients. All eyes were examined with Scheimpflug photography pre-CXL and 1 and 5 months post-CXL. Corneal light scattering was recorded throughout corneal thickness at 8 measurement points 0.0 to 3.0mm from the central cornea.

After CXL, central corneal light scattering increased significantly after 1 month. Corneal light scattering decreased after 6 months but stayed higher than pre-CXL values.

Light scattering at 1 month was more defined in the superficial stroma and gradually reduced to zero at 240μm depth. It was found that corneal light scattering was greater at the corneal centre. The second peak of light scattering occurred 6 months postoperatively between 240μm and 340μm depth.It was also concluded that Scheimpflug photography is useful for corneal light scattering.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.